HomeCompareKRNTY vs PFE

KRNTY vs PFE: Dividend Comparison 2026

KRNTY yields 2.20% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KRNTY wins by $583.7K in total portfolio value
10 years
KRNTY
KRNTY
● Live price
2.20%
Share price
$67.25
Annual div
$1.48
5Y div CAGR
66.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$633.2K
Annual income
$406,130.91
Full KRNTY calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — KRNTY vs PFE

📍 KRNTY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKRNTYPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KRNTY + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KRNTY pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KRNTY
Annual income on $10K today (after 15% tax)
$187.06/yr
After 10yr DRIP, annual income (after tax)
$345,211.27/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, KRNTY beats the other by $322,891.37/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KRNTY + PFE for your $10,000?

KRNTY: 50%PFE: 50%
100% PFE50/50100% KRNTY
Portfolio after 10yr
$341.4K
Annual income
$216,194.81/yr
Blended yield
63.33%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

KRNTY
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
2.2
Piotroski
7/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KRNTY buys
0
PFE buys
0
No recent congressional trades found for KRNTY or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKRNTYPFE
Forward yield2.20%6.13%
Annual dividend / share$1.48$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR66.1%13.2%
Portfolio after 10y$633.2K$49.6K
Annual income after 10y$406,130.91$26,258.71
Total dividends collected$590.1K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldHold

Year-by-year: KRNTY vs PFE ($10,000, DRIP)

YearKRNTY PortfolioKRNTY Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$11,066$365.54$9,153$693.39+$1.9KKRNTY
2$12,468$627.91$8,593$849.25+$3.9KKRNTY
3$14,439$1,098.27$8,336$1,066.78+$6.1KKRNTY
4$17,424$1,974.40$8,437$1,384.80+$9.0KKRNTY
5$22,342$3,698.59$9,013$1,875.40+$13.3KKRNTY
6$31,269$7,362.07$10,306$2,680.72+$21.0KKRNTY
7$49,452$15,994.17$12,820$4,101.38+$36.6KKRNTY
8$92,179$39,266.27$17,673$6,826.70+$74.5KKRNTY
9$212,253$113,621.28$27,543$12,591.86+$184.7KKRNTY
10$633,242$406,130.91$49,560$26,258.71+$583.7KKRNTY

KRNTY vs PFE: Complete Analysis 2026

KRNTYStock

Krones AG, together with its subsidiaries, plans, develops, and manufactures machines and lines for the production, filling, and packaging technology in Germany and internationally. It operates in two segments, Machines and Lines for Product Filling and Decoration, and Machines and Lines for Beverage Production/Process Technology. The company provides process technology systems for use in beer, craft beer, juice, milk, soft drink, water, and spirit; Steinecker phoebus membrane filters; systems for ozonisation of water; bottle design; stretch blow molders; bottle washing machines; filling technology systems; inspection technology systems; labelers; conveyors; product treatment systems; packaging technology systems; palletizing technology systems; block technology systems; and recycling systems. It also offers solutions for intralogistics, material flow technology, or warehousing for the beverage and food sector; and IT solutions. It serves breweries; beverage producers; and companies from the food, chemical, pharmaceutical, and cosmetic industries. Krones AG was founded in 1951 and is headquartered in Neutraubling, Germany.

Full KRNTY Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this KRNTY vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KRNTY vs SCHDKRNTY vs JEPIKRNTY vs OKRNTY vs KOKRNTY vs MAINKRNTY vs JNJKRNTY vs MRKKRNTY vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.